Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy
Clinical trial NCT05747794 · TERMINATED
Trial details
- NCT number
- NCT05747794
- Sponsor
- Immutep S.A.S.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-22
- Primary completion
- 2026-04-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.